Invention Grant
- Patent Title: Prognostic gene expression signature for non small cell lung cancer patients
- Patent Title (中): 非小细胞肺癌患者的预后基因表达特征
-
Application No.: US12602287Application Date: 2008-06-02
-
Publication No.: US08969000B2Publication Date: 2015-03-03
- Inventor: Paul Roepman , Nico Van Zandwijk , Annuska Maria Glas
- Applicant: Paul Roepman , Nico Van Zandwijk , Annuska Maria Glas
- Applicant Address: NL Amsterdam
- Assignee: Agendia B.V.
- Current Assignee: Agendia B.V.
- Current Assignee Address: NL Amsterdam
- Agency: Hoffmann & Baron, LLP
- Priority: EP07109466 20070601
- International Application: PCT/NL2008/050342 WO 20080602
- International Announcement: WO2008/147205 WO 20081204
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The invention relates to a method of typing non-small cell lung cancer by determining RNA levels for a set of genes. The typing can be used for determining a metastasizing potential of the cancer cells. The invention further relates to a set of probes and a set of primers for typing non-small cell cancer cells.
Public/Granted literature
- US20100184052A1 PROGNOSTIC GENE EXPRESSION SIGNATURE FOR NON SMALL CELL LUNG CANCER PATIENTS Public/Granted day:2010-07-22
Information query
